// App-Quantinova.ai

TCT-425 : Real-World Experience with Absorb(tm) Bioresorbable Scaffold Technology - Early Australian Registry Results

Researchers

Presenter

  • Nigel Jepson

Principal Investigators

  • Clare Arnott

  • Liam Back

  • Sze-Yuan Ooi

  • Mark Pitney

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Renal insufficiency

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved